In a separate model assessing protective factors only, both stx1 (OR = 0.02, CI = 0.002-0.1) and stx2c (OR = 0.2, CI = 0.03-0.7) were independently associated with reduced risk of HUS (Table 3). This evidence concerns the gene STX1A and hemolytic-uremic syndrome.